Facebook
X
LinkedIn
ForwardMayo Clinic Nephrology, Hypertension and Kidney Transplantation Update for the Clinician 2026
This course offers Live (in-person) and Livestream (virtual) attendance options
Division Chairs: Harini Chakkera, M.D., M.P.H., Arizona, LaTonya Hickson M.D., Florida, Tambi Jarmi, M.D., Florida, and Vesna D. Garovic. M.D., Ph.D., Minnesota
Course Directors: Raymond L. Heilman, M.D., Pooja Budhiraja, M.B.B.S., and Evamaria Anvari, M.D.
Course Co-Directors: Ladan Zand, M.D., Ziad Zoghby, M.D., M.B.A., Hatem Amer, M.D., Hani M. Wadei, M.D., and Ivan E. Porter, II, M.D.
February 13 - 15, 2026 - Scottsdale, Arizona
The Mayo Clinic Nephrology, Hypertension and Kidney Transplantation Update for the Clinician 2026 is a three-day symposium designed to update participants on a range of nephrology topics relevant to current medical practice. Through a combination of lectures, literature review, and case-based presentations, this symposium delivers up-to-date and cutting-edge information that can be directly integrated into clinical practice.
This program is endorsed by the following organizations:
 | ERA‘s endorsement is for the promotion of education in general, therefore the specific content of the event/course is the responsibility of the organiser |
 | ASN’s endorsement is for the promotion of nephrology education. The specific content of this program is the responsibility of the organizing committee and not ASN. |
 | Endorsed by the American Society of Transplantation. |
Abstract Session - January 2, 2026
As part of the Mayo Clinic Nephrology, Hypertension and Kidney Transplantation Update for the Clinician 2026, a Poster Session for presentation of original research and challenging cases dedicated to the fields of Nephrology, Hypertension, and Transplant will be held at this meeting. Accepted abstract recipients will be chosen from all abstracts received by the submission deadline. Registration is required for all poster presenters. For further information email FLA CME Abstracts.
Target Audience
This symposium is intended for members of the nephrology community and will be of interest to nephrologists, nephrology trainees, nurse practitioners, physician assistants, internists, primary care physicians and other specialists who participate in the care of patients with kidney disorders and kidney and/or pancreas transplants.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Apply evidence-based therapies in managing key glomerular diseases.
- Review advanced treatment strategies for resistant and high-risk hypertension, including management of hypertension in pregnancy.
- Describe the clinical application of artificial intelligence (AI) in nephrology.
- Incorporate multidisciplinary strategies to manage post-transplant complications, including chronic allograft dysfunction and related risks.
- Review evidence-based strategies to identify and manage nephrotoxic risks in oncology patients.
Attendance at any Mayo Clinic course does not indicate or guarantee competence or proficiency in the skills, knowledge or performance of any care or procedure(s) which may be discussed or taught in this course.
Additional Information
| Attachment | Size |
|---|---|
 https://www.era-online.org/events/glasgow | 33.14 KB |
ONLY General Session will be offered as Livestream - the Allied Health Track Sessions and What’s New in Transplant Nephrology Session will NOT be livestreamed.
Mayo Clinic Nephrology, Hypertension and Kidney Transplantation |
Fairmont Scottsdale Princess |
February 13-15, 2026 |
All Presentations Mountain Standard Time |
Friday, February 13, 2026 | |||
7:00 am | Registration, Breakfast and Exhibits |
| |
7:50 am | Welcome Introductions |
| |
8:00 am | Title TBA Karl A. Nath, M.D., Mayo Clinic Rochester |
| |
| Glomerulonephritis Session |
| |
8:30 am | IgA Nephropathy in 2025: Evolving Therapies Ladan Zand, M.D., Mayo Clinic Rochester |
| |
9:00 am
| Membranous Nephropathy in the ERA of anti-PLA2R antibodies Fernando C. Fervenza, M.D., Ph.D., Mayo Clinic Rochester |
| |
9:30 am
| Podocytopathy Evamaria Anvari, M.D., Mayo Clinic Arizona |
| |
9:45 am | Q and A |
| |
10:00 am | Coffee Break and Exhibits |
| |
| Glomerulonephritis Session |
| |
10:30 am | Lupus Nephritis: redefining treatment goals |
| |
11:00 am | Myeloma/ Monoclonal Gammopathy of Renal Significance (MGRS) – Diagnosis and Management |
| |
11:30 am | Treatment of C3 and immune complex MPGN |
| |
12:00 pm | Q and A |
| |
12:15 pm | Lunch and Exhibits |
| |
| GN Session | Allied health track |
|
1:15 pm | Post-transplant –recurrent GN | Acute Kidney Injury: What’s New in Prevention and Recovery? |
|
1:45 pm | Clinicopathologic Conference Case Based Discussion Evamaria Anvari, M.D., Mayo Clinic Arizona | 1:45 pm HTN Cases |
|
2:15 pm Emerging Trends in Dialysis Care |
| ||
2:45 pm | Q and A | Q and A |
|
3:00 pm | Coffee Break and Exhibits |
| |
| GN and Genetics Session | Allied health track |
|
3:30 pm | Uses of Plex in nephrology | Management of failing allograft |
|
4:00 pm | Genetics and kidney disease | Nutrition in kidney disease |
|
4:30 pm | Q and A | Q and A |
|
4:45 pm | Welcome Reception, Poster Session and Networking |
| |
6:00 pm | ADJOURN – End of Day 1 |
| |
Saturday, February 14, 2026 | |||
7:00 am | Registration, Breakfast and Exhibits |
| |
7:55 am | Welcome Introductions |
| |
| Pressure. Perfusion. Inflammation Session |
| |
8:00 am | What you need to know about the 2025 AHA/ACC High BP Guideline |
| |
8:30 am | Heart Meets Kidney: Navigating the Crosstalk in Cardiorenal Syndrome |
| |
9:00 am | The Changing Landscape of ANCA Vasculitis |
| |
9:30 am | Q and A |
| |
9:45 am | Coffee Break and Exhibits |
| |
| Onco-nephrology Session | Allied health track – General |
|
10:15 am | Immune Checkpoint Inhibitors: Navigating the Nephrotoxic Frontier | The Leaky Glomerulus: Understanding and Managing Proteinuria. |
|
10:45 am | Toxic Tradeoffs: Balancing Chemotherapy and Kidney Health | Pharmacologic Considerations in Renal Replacement Therapy |
|
11:15 am | Immune Checkpoint Inhibitors in Kidney Transplant: Between Rejection and Remission | Kidney Stone Prevention: Medical Management |
|
11:45 am | Q and A | Q and A |
|
12:00 pm | Lunch and Exhibits |
| |
| Transplant Session | Allied Health Track – Transplant |
|
1:15 pm | Kidney Transplantation in Older Adults: Evidence, Eligibility, and Evolving Practice | Skin, PTLD, and Beyond: The Changing Landscape of Post-Transplant Malignancy |
|
1:45 pm | CNI-Free Zones: Rethinking Maintenance of Immunosuppression | Silent Threats: Opportunistic Infections After Kidney Transplantation |
|
2:15 pm | Q and A | Q and A |
|
2:30 pm | Coffee Break and Exhibits |
| |
| Transplant Session | Allied Health Track – Transplant |
|
2:45 pm | Before and After the Graft: Managing Metabolic Risk Across the Transplant Continuum | Rejection in kidney transplant |
|
3:15 pm | Chronic Allograft Dysfunction: Identifying and Managing Immune and Nonimmune Drivers | Simultaneous pancreas and Kidney transplant– eligibility, complications, recovery, patient and graft outcomes |
|
3:45 pm | Q and A | Q and A |
|
4:00 pm | ADJOURN – End of Day 2 |
| |
Sunday, February 15, 2026 | |||
7:00 am | Registration, Breakfast and Exhibits |
| |
7:55 am | Welcome Introductions |
| |
| Innovation and Evolving Frontiers in Nephrology |
| |
8:00 am | HTN in pregnancy: Diagnosis and treatment in 2026 |
| |
8:30 am | Advances in Regenerative Nephrology |
| |
9:00 am | Immunosuppression Strategies to Improve Kidney Function in Liver Transplant Patients |
| |
9:30 am | Q and A |
| |
| Workshop: Artificial Intelligence in Nephrology |
| |
9:45 am | The use of AI-based image analysis to improve kidney care in patients |
| |
10:15 am | Applications of AI in Nephrology |
| |
10:45 am | AI in Renal Pathology: Transforming Tissue Interpretation |
| |
11:15 am | Q and A |
| |
11:30 am | Coffee Break and Exhibits |
| |
| Advances in Clinical Nephrology | What’s New in Transplant Nephrology |
|
11:45 am | 2026 ADPKD Update: Changing the Course of Cystic Disease | Living Donor Kidney Transplantation in 2026: What’s New, What’s Next |
|
12:15 pm | Current therapies for slowing CKD progression | Beyond creatinine: new biomarkers |
|
12:45 pm | Updates in clinical nephrology | Updates in transplant nephrology
|
|
1:15 pm | Q and A | Q and A |
|
1:30 pm | Closing Remarks |
| |
1:45 pm | ADJOURN – End of Day 3 |
| |
Experience the Fairmont Scottsdale Princess, a AAA Five Diamond resort set against the stunning backdrop of the Sonoran Desert. This luxurious oasis combines Southwestern charm with modern luxury, offering a blend of elegance and contemporary design. Enjoy five award-winning dining experiences, sparkling pools, a world-class spa, and championship golf courses.
A block of rooms has been reserved for attendees at a group rate starting at $389 per night, plus applicable fees and taxes. Make your reservations before the room block sells out or before the expiration date of January 16, 2026, whichever comes first. The discounted room reservation link will be included in the confirmation email after enrollment is complete.
All travel and lodging expenses are the sole responsibility of the individual registrant.
Division Chairs
Harini Chakkera, M.D., Arizona
Vesna D. Garovic. M.D., Ph.D., Minnesota
LaTonya Hickson M.D., Florida
Tambi Jarmi, M.D., Florida
Course Directors
Pooja Budhiraja, M.B.B.S., Arizona
Evamaria Anvari, M.D., Arizona
Raymond L. Heilman, M.D., Arizona
Course Co-Directors
Hani M. Wadei, M.D., Florida
Ivan E. Porter, II, M.D., Florida
Ladan Zand, M.D., Minnesota
Ziad Zoghby, M.D., M.B.A., Minnesota
Hatem Amer, M.D., Minnesota
Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Credit Statement(s):
AMA
Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 18.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AAPA
Mayo Clinic College of Medicine and Science has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 18.25 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
ANCC
Mayo Clinic College of Medicine and Science designates this activity for a maximum of 18.25 ANCC contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
ACPE
Mayo Clinic College of Medicine and Science designates this educational activity for a maximum of 18.25 ACPE Knowledge-based contact hours. Participants should claim only the credit commensurate with the extent of their participation in the activity.
UAN Number: JA0000238-0000-26-018-L01-P
IPCE
This activity was planned by and for the healthcare team, and learners will receive 18.25 Interprofessional Continuing Education (IPCE) credit for learning and change.
Other Healthcare Professionals:
A record of attendance will be provided to all registrants for requesting credits in accordance with state nursing boards, specialty societies or other professional associations.
| Day | Credit(s) |
|---|---|
| Friday | 6.75 |
| Saturday | 6.00 |
| Sunday | 5.50 |
For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.
Available Credit
- 18.25 AAPA Category 1
- 18.25 ACPE
- 18.25 AMA PRA Category 1 Credit™
- 18.25 ANCC
- 18.25 Attendance
- 18.25 IPCE
To exhibit at this activity please complete and submit the Exhibit Agreement Form below. Exhibit Space availability is based on the order completed forms are submitted until space runs out. Exhibit space is not confirmed until the submitting representative is notified of their confirmation by a member of the Mayo Clinic School of Continuous Professional Development.
PROSPECTUS: View the prospectus to see available Exhibit and Sponsorship opportunities and complete the Letter of Agreement to request your space.
ONLY General Session will be offered as Livestream - the Allied Health Track Sessions and What’s New in Transplant Nephrology Session will NOT be livestreamed.
| Course Registration Fees | Before 01/12/26 | After 01/13/26 |
| Physicians and Scientists | $699 | $774 |
| Residents, Fellows, PAs, NPs and Allied Health | $549 | $624 |
Please update your profile to let us know if you have dietary restrictions or access requirements.
To claim credit for livestream participation in this course, learners must view the content during the hours posted for the live activity. This course is not approved for on-demand delivery.
Commitment to Belonging and Inclusion
Mayo Clinic School of Continuous Professional Development (MCSCPD) strives to foster a learning environment in which all individuals are valued, allowing all to achieve their fullest potential.
Cancellation and Refund Policy
View Cancellation and Refund Policy
All requests must be submitted in writing using the Contact Us Form.
Any use of this site constitutes your agreement to the Terms and Conditions of Registration.